RPS6 and neoplasm: Metformin decreased tumor Ki-67, phospho-AMPK, phospho-Akt, phospho-rpS6, phospho-4E-BP-1 and ER but did not change PR levelResponders had increased serum free fatty acids and tumor staining for markers of fatty acid oxidation and glycogen synthesis